With heightened excitement centering on the recent announcement by Merck that its investigational antiviral therapy molnupiravir reduces the risk of hospitalization due to COVID-19, the…
Merck and partner Ridgeback Biotherapeutics submitted an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for Molnupiravir, the oral antiviral medication…
While mass media article after article attacks ivermectin as horse medication of anti-vaxxers, in the meantime, the National Institutes of Health (NIH) have more formally…
Merck’s molnupiravir has certainly received a lot of good press over the past days since the New Jersey-based pharmaceutical company announced its clinical trial demonstrates…
According to Vietnamese media, the Vietnamese health ministry added 400 mg Molnupiravir to its COVID-19 treatment protocol, which also includes Favipiravir and Remdesivir. TrialSite reported…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
